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The vesicular glutamate transporter 3 (VGLUT3) is expressed at several locations not
normally associated with glutamate release. Although the function of this protein has been
generally elusive, when expressed in non-glutamatergic synaptic terminals, VGLUT3 can
not only allow glutamate co-transmission but also synergize the action of non-glutamate
vesicular transporters. Interestingly, in the immature glycinergic projection between the
medial nucleus of the trapezoid body (MNTB) and the lateral superior olive (LSO) of
auditory brainstem, the transient early expression of VGLUT3 is required for normal
developmental refinement. It has however been unknown whether the primary function
of VGLUT3 in development of these inhibitory synapses is to enable glutamate release or
to promote loading of inhibitory neurotransmitter through vesicular synergy. Using tissue
from young mice in which Vglut3 had been genetically deleted, we evaluated inhibitory
neurotransmission in the MNTB-LSO pathway. Our results show, in contrast to what has
been seen at adult synapses, that VGLUT3 expression has little or no effect on vesicular
synergy at the immature glycinergic synapse of brainstem. This finding supports the
model that the primary function of increased VGLUT3 expression in the immature auditory
brainstem is to enable glutamate release in a developing inhibitory circuit.
Keywords: co-transmission, lateral superior olive, medial nucleus of trapezoid body, vesicular transport proteins,
inhibitory synapses, development
INTRODUCTION
The glycinergic projection from the medial nucleus of the
trapezoid body (MNTB) to lateral superior olive (LSO) is a
critical component of the neural circuit for localizing higher
frequency sound sources (for review, see Tollin, 2003, though see
also Jalabi et al., 2013). Although the MNTB-LSO pathway, with
its precise, tonotopically organized circuitry and well-defined
inputs, has been a model system for understanding inhibitory
circuit refinement, the mechanisms of this synaptic refinement
have yet to be elucidated, in part because immature MNTB-LSO
synapses exhibit a complex neurotransmitter phenotype. First,
as is common at other immature glycinergic synapses, MNTB
terminals in the LSO use GABA transmission (Kotak et al.,
1998; Nabekura et al., 2004), for unknown reasons (Gillespie
and Kandler, 2009). Second, due to the transient expression of
vesicular glutamate transporter 3 (VGLUT3), MNTB terminals
also release glutamate during the first postnatal week (Gillespie
et al., 2005), a period characterized by major synaptic refine-
ment (Kim and Kandler, 2003). As hearing onset does not occur
until about postnatal day 10 (P10), this circuit refinement is
understood to be directed by neural activity spontaneously gen-
erated in the cochlea (Tritsch et al., 2007), and the expression of
VGLUT3 is required for normal refinement (Noh et al., 2010).
The precise role of VGLUT3 in this refinement has not been
elucidated.
The function of VGLUT3 in the nervous system generally
has been elusive. Although originally identified by sequence
homology with its more common family members Vglut1 and
Vglut2, Vglut3 has a distinctly different expression pattern and
likely function. First, VGLUT3 exhibits a biphasic temporal
expression pattern, with intense, transient expression in
immature cerebellum and brainstem. Additionally, in both
neonatal and adult tissue, VGLUT3 is notably expressed at
“non-glutamatergic” release sites (Fremeau et al., 2002; Gras
et al., 2002, 2005; Herzog et al., 2004). This seemingly ectopic
expression of VGLUT3 naturally led to an initial hypothesis that
a primary function might be to enable glutamate release from
non-canonical glutamate synapses and/or from astrocytes. More
recently, however, another role has come to light. In particular,
in the striatum and raphe nucleus of adult, VGLUT3 is targeted
to cholinergic and serotonergic vesicles where it synergizes the
action of vesicular transporters for acetylcholine and serotonin,
increasing both rate and degree of vesicle filling (Gras et al., 2008;
Amilhon et al., 2010; for review, see El Mestikawy et al., 2011).
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In the MNTB-LSO pathway, the working model for
the role of VGLUT3 in functional refinement has been
that depolarizing GABA and/or glycine at the immature
MNTB-LSO synapse relieves Mg++-block at NMDA receptors
that, upon their activation by glutamate co-transmission,
mediate activity-dependent plasticity (Kandler and Friauf,
1995; Kotak et al., 1998; Ehrlich et al., 1999; Kalmbach et al.,
2010; Case and Gillespie, 2011). A central assumption of
this model is that VGLUT3 is expressed in the developing
auditory brainstem primarily to enable glutamate release
from immature glycinergic synapses. The possibility that
VGLUT3 could synergize packaging of GABA/glycine vesicles
in immature MNTB terminals, however, gives rise to an
alternate hypothesis for why developmental refinement here
requires VGLUT3. In the alternate model, at what would
otherwise be a sluggish immature synapse, VGLUT3 boosts
GABA/glycinergic transmission, activating L-type voltage-gated
Ca++ channels (Kullmann et al., 2002) that could lead to
downstream plasticity.
If VGLUT3 permits or directs refinement of MNTB-LSO
synapses by boosting GABA/glycinergic vesicle loading, we would
expect loss of VGLUT3 to cause abnormal GABA/glycinergic
transmission during the period of major circuit refinement. Using
whole-cell recordings in tissue from genetically altered mice, we
found that VGLUT3 expression does not synergize GABA/glycine
vesicle loading in the developing MNTB-LSO circuit.
MATERIALS AND METHODS
All procedures adhered to Canadian Council on Animal Care
guidelines and were previously approved by the Animal Research
Ethics Board of McMaster University. Mice heterozygous (+/−)
for Vglut3 (gift of S. El Mestikawy) were bred on site to
yield litters containing wild-type (WT), heterozygous (het), and
knockout (KO) mice. Genotypes were determined after all other
procedures had been performed, to ensure that slice preparation
and electrophysiology were always performed blind to Vglut3
expression.
Pups age postnatal day 4–5 (P4–5; day of birth is P0)
were anesthetized and quickly decapitated, and the brains were
removed into ice-cold artificial cerebrospinal fluid (ACSF, pH
7.2) containing (in mM): 125 NaCl, 1 MgSO4, 5 KCl, 1.25
KH2PO4, 10 dextrose, 26 NaHCO3, 2 CaCl2, 1 ascorbic acid, 1
kynurenic acid. Tail tissue for subsequent genotype determination
was collected at sacrifice. Brainstem slices (300 µm) containing
the MNTB and LSO were allowed to recover at room temperature
for ≥1 h in a humidified, oxygenated, interface chamber. Slices
were transferred to a recording chamber where they were continu-
ously perfused with ACSF at elevated temperature (32–35◦C) and
superfused with 95% O2/5% CO2. Perfusion ACSF was identical
to slicing ACSF, with the addition of 0.3 mM ascorbic acid and 0.5
mM D-glutamine.
Recording electrodes (1–4 MΩ) were filled with a Cs-gluconate
solution containing (in mM): 64 D-gluconic acid, 64 CsOH, 11
EGTA, 56 CsCl, 1 MgCl2, 1 CaCl2, 10 HEPES, 0.3 GTP-Na, 4
ATP-Mg, 0.1 mM spermine (Acros Organics). In several cases,
the internal solution also contained 0.5% biocytin for histological
verification of cell type; in some instances QX-314 (5 mM; Tocris)
was added to the internal solution to increase patch stability. Prin-
cipal cells in the medial and middle limbs of the LSO were visually
identified under IR-DIC by their morphology and orientation and
were patched in whole-cell mode. Recordings were sampled at
10 kHz, and filtered at 5 kHz. Series resistance was compensated
by 80% with < 10 µs lag, and recordings were discarded if
series resistance changed by ≥15%. All recordings were made
at a holding potential of −60 mV. Data were saved for offline
analysis using MiniAnalysis (Synaptosoft), Clampfit (Molecular
Devices) or custom Matlab programs, and are presented as mean
+/− S.E.M.
In each slice, a stimulating electrode was placed at the lateral
edge of the MNTB, the minimum intensity that reliably elicited a
response was determined, and stimulus intensity thereafter was
unaltered throughout the experiment. Within pulse trains, the
peak current amplitude for each pulse was measured relative
to current immediately before the pulse; all paired-pulse ratios
(PPRs) are reported with the amplitude of the first response in
the denominator.
To estimate quantal content and probability of release, we
delivered 20 electrical stimuli at 100 Hz and normalized the
amplitude of each response in the train to the amplitude of the
first response. We then performed a linear regression on the
last 6 points in the cumulative response amplitude curve and
extrapolated to time = 0 (response 1) to estimate the size of the
readily releasable pool of vesicles multiplied by quantal amplitude
(Nq) (Inchauspe et al., 2007), and thence to estimate probability
of release.
Spontaneous miniature GABA/glycinergic events are
uncommon in the immature LSO. To increase the probability
of observing miniature GABA/glycinergic events, we delivered
high-frequency stimulation (20 pulses at 100 Hz) to MNTB
fibers, or replaced CaCl2 in the ACSF with SrCl2 (2 mM) to
promote asynchronous vesicular release. Miniature events were
identified, individually verified, and analyzed in MiniAnalysis. For
comparison and verification, a subset of miniature events was also
analyzed in Clampfit. As results from the two analyses showed no
differences, all results shown here were analyzed in MiniAnalysis.
DNA was isolated from tail tissue obtained at sacrifice, and
polymerase chain reaction (PCR) reactions using VGlut3 WT
(278 bp) and VGlut3 KO cassette (604 bp) primers (Gras et al.,
2008; Mobix Lab, McMaster University) were completed in
separate tubes in a Peltier Thermal Cycler (Dyad DNA Engine).
Following the PCR reaction, primer bands were identified using
gel electrophoresis.
RESULTS
If the vesicular synergy model holds true in the immature
MNTB-LSO pathway, we would expect differing levels of Vglut3
to correlate with differences in GABA/glycinergic transmission,
in particular for measures of short-term plasticity, recovery from
short-term depression, and quantal size. For example, if VGLUT3
promotes faster vesicle reloading, VGLUT3-expressing synapses
might be expected to recover more quickly from short-term
depression. More specifically, we predicted that quantal size and
hence the amplitude of miniature synaptic events would be larger
at MNTB-LSO synapses expressing VGLUT3.
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FIGURE 1 | Stimulation at 50 Hz in the MNTB revealed no effect of
genotype on release properties in the LSO. (A) Representative
responses to 50 Hz stimulation for WT (P4), het (P5), and KO (P4) tissue.
(B) Example traces from (A), scaled for comparison. Traces were first
scaled to force all genotypes to have the same value for the amplitude of
the first response; then, within each train, the baseline for each response
was reset to zero (i.e., baseline for first-response). (C) No differences
appeared between WT (n = 20), het (n = 49), and KO (n = 9) mice for
paired-pulse ratios (C; p = 0.32, see text). (D) Application of the mGluR
antagonist LY 341 495 had no effect on PPR in slices expressing VGLUT3.
Example P5 WT slice.
Normal developmental refinement in the murine MNTB-
LSO pathway, which is characterized by changes in quantal size,
quantal content, and probability of release (Kim and Kandler,
2010), is perturbed in VGlut3−/− mice (Noh et al., 2010).
Therefore, to minimize the likelihood of measuring differences
that had resulted from an ultimate effect of VGLUT3 on synaptic
refinement rather than a proximal effect on vesicular synergy, we
restricted our recordings to tissue from animals P4-P5. At this
age in LSO, VGLUT3 levels and glutamate release are relatively
high and the synaptic changes associated with the major period
of developmental refinement have just begun. To avoid possible
bias, all tissue collection, recordings, and analyses were performed
blind to genotype.
VGLUT3 EXPRESSION DOES NOT AFFECT GABA/GLYCINE RELEASE
UPON 50 HZ STIMULATION
We first wanted to determine whether PPRs differ between VGlut3
WT, heterozygous (het), and KO mice. We made whole-cell
recordings in the LSO while delivering pulse trains to MNTB
fibers at frequencies previously shown to cause short-term depres-
sion at immature MNTB-LSO synapses (Kim and Kandler, 2010;
Case and Gillespie, 2011). Most cells exhibited depression consis-
tent with previous results; the small number of anomalous cells
that exhibited facilitation (n = 1 WT, 4 het, 2 KO) were excluded
from analysis. Representative responses (for PPR) to stimulation
at 50 Hz in the MNTB (Figures 1A,B) show no influence of
genotype on PPR. We note that the responses depicted here
were chosen by selecting for each condition the response with
median PPR. It happens that the WT recording with median
PPR response (shown) exhibited a background tonic current not
seen in the median responses for the het and KO conditions.
However, this tonic current is atypical; it was not characteristic,
it did not occur more often in any particular genotype, and it
did not affect PPR (data not shown). For the population of cells
stimulated at 50 Hz, we found no effect of genotype on PPR
(Figure 1C; PPRs: WT = 0.79 +/− 0.05, n = 21; het = 0.75
+/− 0.02, n = 49; KO = 0.83 +/− 0.08, n = 9; Kruskal-Wallis
test: p = 0.32). Co-expression of VGLUT3 with other vesicular
transporters has been shown to increase the rate and extent to
which synaptic vesicles are filled (Gras et al., 2008; Amilhon et al.,
2010). If VGLUT3 synergizes vesicle filling and if vesicle filling is
a rate-limiting step, we would expect synapses from KO tissue to
follow high frequency stimulation less well than those from WT
or het tissue. Thus, these results do not support vesicular synergy
between VGLUT3 and the GABA/glycine vesicular transporter
(VIAAT/VGAT).
In the neonatal rat LSO, repetitive stimulation of the
glutamatergic afferents from the ipsilateral cochlear nucleus can
cause mGluR-mediated modulation of inhibitory neurotrans-
mission at MNTB terminals (Nishimaki et al., 2007). To ask
whether the presumably smaller amount of glutamate released
by MNTB terminals could similarly modulate release properties,
we compared pulse trains before and after the application of the
mGluR2/3 antagonist LY 341 495 (Tocris) in a separate set of
3 WT slices (example shown in Figure 1D). Because blocking
mGluRs did not affect paired pulse ratios or current amplitudes
in any instance, we did not include the antagonist in further
studies.
VGLUT3 EXPRESSION DOES NOT AFFECT GABA/GLYCINE RELEASE
UPON 100 HZ STIMULATION
Adult neurons in the auditory brainstem achieve high rates of
neural activity, and so, even in young tissue, it is possible that
50 Hz stimulation is simply too slow to test the system. In a
new set of slices, we therefore stressed the synapse further by
delivering stimuli at 100 Hz to the MNTB while recording in
the LSO. Representative recordings from WT, het, and KO mice
following 100 Hz stimulation are shown in Figure 2A, and these
traces are shown overlaid in Figures 2B,C (normalized to the
highest amplitude recording, the WT cell, in Figure 2A). With the
faster 100 Hz stimulation, we still found no effect of genotype
on paired-pulse depression (Figure 2D; PPRs: WT = 0.68 +/−
0.09, n = 8; het = 0.68 +/− 0.08, n = 9; KO = 0.64 +/− 0.09,
n = 8; Kruskal-Wallis: p = 0.75), or on cumulative normalized
amplitude of the pulse train (Figure 2E; cumulative amplitudes
of 20 responses: WT = 8.06 +/− 0.86, n = 8; het = 7.43
+/− 0.74, n = 9; KO = 6.68 +/− 0.81, n = 8; Kruskal-Wallis:
p = 0.28).
From the same cells, using cumulative amplitude to estimate
quantal content Nq and probability of release (see Methods), we
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FIGURE 2 | Stimulation at 100 Hz in the MNTB revealed no effect of
genotype on release properties in the LSO. To more stringently test for
differences in release properties, we delivered 20 pulses at 100 Hz in tissue
from WT (n = 8), het (n = 9), and KO (n = 8) mice. (A) Representative
responses to 100 Hz trains of 20 pulses for WT (P4), het (P4), and KO (P4)
tissue. (B) Example traces from (A), scaled for comparison. Traces were first
scaled to force all genotypes to have the same value for
first-response-amplitude; then, within each train, the baseline for each
response was reset to zero (i.e., baseline for first-response). (C) First 5
responses from examples in (B), enlarged for clarity. (D,E) No differences
were apparent between WT (n = 8), het (n = 9) and KO (n = 8) tissue for
paired-pulse ratios (D; p = 0.75, see text) or cumulative event amplitudes (E; p
= 0.28, see text). Probability of release, as estimated using these cumulative
amplitude functions, was also similar among genotypes (see text).
found similar estimates for Nq and release probability between
genotypes (Figure 2E; Nq: WT = 3.1 +/− 0.3; het = 2.8 +/−
0.3; KO = 3.2 +/− 0.4; Kruskal-Wallis test, p = 0.74; release
probability: WT = 0.35 +/− 0.04; het = 0.39 +/− 0.05; KO = 0.35
+/− 0.05; Kruskal-Wallis test, p = 0.71). Together, these results
argue that VGlut3 expression does not affect release properties for
GABA/glycine at MNTB terminals.
VGLUT3 EXPRESSION DOES NOT AFFECT RECOVERY FROM
DEPRESSION FOLLOWING 50 HZ STIMULATION
Though our pulse train experiments had failed to show
obvious effects of VGlut3 expression on release proper-
ties, we considered the possibility that differences in vesi-
cle re-filling might affect synaptic transmission on a longer
timescale, and that this might be observed as an effect on
recovery from depression. To test this model, we delivered
two 50 Hz 10-pulse trains, separating by varying intervals
(Dittman and Regehr, 1998) in order to estimate the time
required for neurotransmission to recover to its original level
(Figure 3A).
Cells were included in this analysis if we were able to test
at least 8 recovery intervals, including one of at least 4 s. In
practice, using these criteria ensured that 90% or greater recov-
ery was attained for all cells analyzed. Percent depression as
a function of recovery interval was then fit to an exponential
(individual cells, Figure 3B; averages, Figure 3C). Neither average
time to 90% recovery (WT: 3.2 +/− 0.7 s, n = 5; het: 2.9 +/−
0.2 s, n = 12; KO: 3.0 +/− 1.0 s, n = 6; Kruskal-Wallis test,
p = 0.76) nor exponential time constants for recovery (recovery
time constants: WT = 2.4 +/− 0.7 s, het = 1.7 +/− 0.2 s,
KO = 1.9 +/− 0.8 s; Kruskal-Wallis test, p = 0.32) differed among
genotypes.
VGLUT3 EXPRESSION DOES NOT AFFECT SIZE OF GABA/GLYCINE
MINIATURE EVENTS
VGLUT3 has been shown to increase not only the rate, but also the
amount of transmitter loading into synaptic vesicles (Gras et al.,
2008). If VGLUT3 increases the concentration of GABA/glycine
in vesicles at MTNB terminals, we would expect KO tissue to
exhibit smaller responses to quantal release. To test this model, we
compared the amplitudes of miniature GABA/glycinergic events
recorded from WT and KO tissue. Because spontaneous vesic-
ular release is uncommon in the immature LSO, we artificially
increased release of single vesicles by either (1) first delivering
brief high frequency stimulation to the MNTB-LSO pathway,
or (2) adding Sr++ to the perfusate to desynchronize vesicular
release in response to single stimuli (Bekkers and Clements, 1999).
Miniature events were collected in the 20 s following the stimulus,
and the individual events were analyzed. Cells were always allowed
to recover at least 20 s before a new stimulus. In the examples
of Figure 4A, no effect of genotype on mean event amplitude
is seen (WT: 537 events, mean amplitude = 25.9 +/− 0.4 pA,
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FIGURE 3 | Recovery from paired-pulse depression was unaffected
by genotype. To determine the time required for MNTB-LSO synapses
to recover from paired-pulse depression, we delivered pairs of 50 Hz
trains of 10 pulses each, with each pair of trains separated by intervals
ranging from 50 ms to 12 s. (A) Left: Three representative responses
used to determine recovery time for a P5 het neuron. In each panel,
Train 1 comprises the responses to the initial pulse train, and Train 2 the
responses to the second pulse train of the pair, delivered after the
interval shown. Right: Percent depression as a function of recovery
interval (8 intervals, 50 ms to 4 s) for the cell shown at the left. Recovery
time constant = 1.56 s; R-square of curve fit = 0.94. (B) Exponential fits
for recovery from depression are shown for each cell thus examined (n
values: WT = 5, het = 12, KO = 6). (C) Average of recovery curves (bold)
for each genotype, with individual recovery curves from (B) in
background (dashed, desaturated curves). Genotype had no effect on
time to recovery from paired-pulse depression (Recovery time constant:
WT = 2.4 +/− 0.7 s, het = 1.7 +/− 0.2 s, KO = 1.9 +/− 0.8 s;
Kruskal-Wallis test, p = 0.32).
median amplitude = 25.0 pA; KO: 326 events, mean amplitude
= 22.1 +/− 0.5 pA, median amplitude = 20.8 pA). This similarity
in event amplitude held true across all cells (Figure 4B; WT:
average mean amplitude = 31.8 +/− 2.4 pA, average median
amplitude = 29.0 pA+/− 2.2 pA, n = 22; KO: average mean ampli-
tude = 31.6 +/− 4.3 pA, average median amplitude = 29.2 pA+/−
3.8 pA, n = 9; t-test for means, p = 0.98; t-test for medians,
p = 0.95). Comparison of current decay times also yielded no
significant difference between genotypes (Figure 4C; WT: average
mean decay = 10.3 +/− 1.5 ms, average median decay = 7.8 +/−
1.1 ms; KO: average mean decay = 11.7 +/− 2.5 ms, average
median decay = 10.6 +/− 2.4 ms; t-test for means, p = 0.65;
t-test for medians, p = 0.23), and even the cumulative proba-
bilities found by pooling all miniatures within genotype showed
only the suggestion of a difference (Figure 4D). Together, these
results provide further evidence that VGlut3 expression does not
appreciably influence GABA/glycine vesicle loading at immature
MNTB terminals.
DISCUSSION
VGlut3 is expressed in select populations of typically non-
glutamatergic neurons. At adult synaptic terminals, VGLUT3
can increase both rate and level of neurotransmitter packing in
cholinergic, serotonergic, and GABAergic vesicles in the striatum,
raphe nuclei and hippocampus (Gras et al., 2008; Amilhon et al.,
2010; Zander et al., 2010), and at least in the striatum VGLUT3
is required for normal cholinergic transmission (Nelson et al.,
2014). To ask whether the transient expression of VGlut3 during
early postnatal development plays a similar role in synergizing
GABA/glycine transmission at immature MNTB terminals in the
LSO, we made whole-cell patch-clamp recordings from VGlut3
WT, heterozygous and KO mice. The similarity among tissue
from WT, het, and KO mice for PPRs and time to recovery from
synaptic depression argues against a primary effect of VGLUT3
on rate of vesicle filling. The similarity in amplitude of miniature
GABA/glycinergic events across genotype further argues against
a model in which VGLUT3 increases level of vesicle filling. As the
only other known function for VGLUT3 is to enable glutamate
release, our results lend further support to the model that normal
developmental refinement in the MNTB-LSO pathway requires
VGLUT3 because refinement requires glutamate release. This
model still needs to be tested explicitly.
We note that VGLUT3 may have exerted a nuanced effect
on GABA/glycine transmission in our samples (e.g., Figure 4D),
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FIGURE 4 | Quantal size, as assessed by miniature events, was
unaffected by genotype. (A) Example miniature events for cells from WT
(left, P5, 537 events, mean = 25.9 +/− 0.4 pA, median = 25.0 pA) and KO
(right, P5, 326 events, mean = 22.1 +/− 0.5 pA, median = 20.8 pA) tissue.
Bold trace is the average miniature event for each cell. Event histograms for
each cell are included below the example traces. (B) No differences were
observed between WT (n = 22) and KO (n = 9) tissue for either mean or
median peak amplitude (means: WT = 31.8 +/− 2.4 pA, KO = 31.6 +/− 4.3 pA;
t-test p = 0.98; medians: WT = 29.0 +/− 2.2 pA, KO = 29.2 +/− 3.8 pA; t-test
p = 0.95). Red markers indicate example cells in (A). (C) For the cells shown
in (B), no differences were observed between WT and KO tissue for either
mean or median decay times (means: WT = 10.3 +/− 1.5 ms, KO = 11.7 +/−
2.5 ms; t-test, p = 0.65; medians: WT = 7.8 +/− 1.1 ms, KO = 10.6 +/− 2.4
ms; t-test, p = 0.23). Red markers indicate example cells in (A). (D)
Cumulative probabilities for all miniature amplitudes, pooled within genotype,
for the cells shown in (B,C).
but if so, it was a small effect, and one that might well
have occurred if already by P4–5 a subset of synapses
had undergone more maturation in WT than in KO mice
(Kim and Kandler, 2010; Noh et al., 2010). It has been nicely
demonstrated that the window for synaptic refinement in the rat
MNTB-LSO pathway is between P3 and P8 (Kim and Kandler,
2003), and in mice, we expect this period to be the same or per-
haps shifted a day earlier. While in theory our question could be
addressed by analyzing tissue collected before the synaptic refine-
ment begins, VGLUT3 expression increases enough between P1
and P5 to cause problems for such an analysis. We note also that if
VGLUT3 normally induces vesicular synergy that is followed by a
compensatory reduction in quantal content (Daniels et al., 2004)
we might miss an effect of VGLUT3 on miniature synaptic events.
Nevertheless, whatever advantage VGLUT3 may provide to
GABA/glycine neurotransmission, clearly that effect is small rela-
tive to the transformative effect of enabling glutamate release from
immature inhibitory terminals. In sum, these results suggest that
VGLUT3 plays qualitatively different roles at neonatal and adult
inhibitory synapses, and in the immature auditory brainstem the
likely primary function of VGLUT3 is to enable glutamate release.
Although VGlut3 is already highly expressed in the superior
olive at P4–5, its expression continues to increase until about
P9–10, after which it declines rapidly (Gras et al., 2005). This
raises the question of whether VGLUT3-induced vesicular synergy
could be more prominent at P9–P10 and we did not observe it
simply because we tested at P4–5. In fact, it would be difficult to
disentangle demonstrated differences in miniature event ampli-
tudes between WT and VGlut3 KO mice at P9–12 (Noh et al.,
2010), which are understood to reflect normal developmental
strengthening due to postsynaptic effects (Kim and Kandler,
2010), from a synergistic effect. Nevertheless, even if any part
of these differences at P9–12 could be attributed to a larger role
for VGLUT3 in vesicular synergy, P9 is already past the window
for functional refinement in the MNTB-LSO pathway (Kim and
Kandler, 2003); hence, vesicular synergy found at P9 could not be
a significant contributor to refinement.
Another possibility that could have obscured a vesicular
synergy effect in our study is if loss of VGLUT3 results in
compensatory presynaptic expression of VGLUT1 or VGLUT2
or increased postsynaptic expression of GABAA and/or glycine
receptors. This seems unlikely. In vesicular synergy studies with
VGlut3 KO mice, compensatory increases in glutamate trans-
porters have not been seen (Gras et al., 2008). Furthermore, if
another vesicular glutamate transporter were upregulated, glu-
tamate release should still be seen in the MNTB-LSO pathway
of VGlut3 KO mice, whereas in fact it disappears (Noh et al.,
2010). Finally, while it is possible that compensatory changes
in the expression of other, unidentified, synaptic proteins could
have prevented our identification of a vesicular synergy effect,
once again, that hypothetical compensatory effect is insuffi-
cient to rescue refinement (Noh et al., 2010), which further
supports the conclusion that supporting vesicular synergy is
not the critical role VGLUT3 plays in MNTB-LSO pathway
refinement.
Normally considered a rare protein, VGLUT3 exhibits a
striking expression profile in the developing superior olive,
increasing dramatically from birth until about P10 and then
declining to nearly undetectable levels (Blaesse et al., 2005;
Cooper and Gillespie, 2011). As this transient expression most
probably reflects a distinctly developmental role for VGLUT3 at
immature inhibitory synapses in the superior olive, our results
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do not contradict but rather complement those reported at
adult synapses. Indeed, whereas mature expression of VGLUT3
can suppress excitability (Zander et al., 2010) and support
synergistic packaging of other neurotransmitters (Gras et al.,
2008; Amilhon et al., 2010), the early expression of VGLUT3 in
the auditory brainstem is required for normal developmental
circuit refinement (Noh et al., 2010).
The refinement for which VGLUT3 is required in the rodent
LSO occurs during the first postnatal week (Kim and Kandler,
2003, 2010), a period during which the brainstem receives no
acoustically driven inputs. Activity-dependent refinement must
therefore rely upon the activity generated spontaneously in the
developing cochlea (Tritsch et al., 2007, 2010), and indeed it
has recently been shown that altering the temporal statistics
of this activity affects circuit refinement (Clause et al., 2014).
As the mechanisms underlying refinement in this inhibitory
circuit are still unknown, the role of VGLUT3 has inspired
speculation. In one proposed role, VGLUT3 enables glutamate
co-transmission to activate NMDA receptors. In the alternate
proposed role, VGLUT3 boosts GABA/glycinergic transmission,
which in turn depolarizes NMDA receptors or activates voltage-
gated Ca++ channels. Our results argue against a primary func-
tion of VGLUT3 in promoting loading of GABA/glycine into
synaptic vesicles in the developing brainstem and highlight the
importance of establishing a robust model for mechanistic studies
of synaptic plasticity and the role of VGLUT3 at this glycinergic
synapse.
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